MD house calls can reduce chances of dying in hospital: Ontario study Diets, the evidence and the media: we need a better solution to obesity Just how bad is all that sugar for the heart? CGRP antagonists: new migraine prevention therapies in current development Monoclonal antibodies targeting the calcitonin gene-related peptide pathway are under study for preventing episodic and chronic migraine Opioid makers gave $10M to U.S. advocacy groups amid epidemic A new government report sheds light on the opioid industry's ability to shape public opinion Global stock markets drop close to 10%. What, me worry? David Stephan, convicted in son's death, removed from 'wellness' expo lineup Other sponsors and vendors are pulling out, and the organizer says he doesn't know if upcoming shows in Calgary and Edmonton will go ahead OxyContin maker will stop promoting opioids to doctors in the U.S. Over the weekend, Purdue said it eliminated more than half its sales staff this week and will no longer send sales representatives to doctors' offices to discuss opioid drugs Baloney Meter: Is advocating against abortion out of line with the charter? Dupixent for moderate-to-severe atopic dermatitis in adults The drug is the first biologic therapy for eczema to be approved in Canada First Previous 214 215 216 217 218 Next Last
